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Endothelin-1 (ET-1) and its receptors on haemorrhoidal tissue:
A potential site for therapeutic intervention
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Objectives: Haemorrhoids is a common anorectal condition that
affects millions worldwide. We studied the potential role of ET-1 and
its (ETA and ETB) receptors in haemorrhoid tissue. Methods: ET-1,
ETA and ETB receptor localisation was studied in haemorrhoids using
autoradiography and immunohistochemistry. Protein expression was
compared between haemorrhoids and normal rectal submucosa
using Western blot analysis. ETA and ETB receptor antagonist effects
on ET-1- and sarafotoxin 6a-induced contraction of human mesen-
teric artery and vein were assessed by myography. Results: There
was dense [125I]-ET-1 binding to haemorrhoidal sections with ETB N
ETA binding (12.7 ± 3 vs 4.4 dpm × 103/mm2, n = 3, NS). Immuno-
histochemistry revealed a higher ETB than ETA receptor immunostain-
ing in haemorrhoidal than in control rectal tissue. This was conﬁrmed
by Western blot analysis where haemorrhoidal ETB receptor protein
levels were about 4-times higher than ETA receptors (78.3 ± 28.0 vs
18.8 ± 3.6 densitometric units, p = 0.026). ETA and ETB receptors
were localised to smooth muscle of mesenteric arteries and veins
with ETB receptors also on endothelium. Myograph studies showed
that the sensitivity and maximum contractile response to ET-1 and
sarafotoxin 6a were greater in mesenteric veins than in arteries
(p b 0.05). Conclusions: ETA and ETB receptors are present in haemor-
rhoids with ETB receptors predominating. Mesenteric veins are more
sensitive than arteries to ET-1-induced contraction, an effect that is
blocked to a greater extent by ETB compared with ETA receptor
antagonists. Since ETB receptors are located on smooth muscle of both
the mesenteric artery and vein ETB agonists may have therapeutic
potential via a constrictor action on haemorrhoidal blood vessels.
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Study was conducted in acute trials on rats anaesthetized with
urethane 100 mg/100 g of body weight. Endothelin-1 0.1 μg/100 g
was injected into the portal vein and 0.9% NaCl (100 μl/100 g) was
administrated to the control animals. Choleresis was estimated in
microlitres, each for 10 min, during a three-hour experiment. Six
half-hour bile samples were collected. Concentration of the bile acids,
and lipids in bile was determined by thin-layer chromatography.
Endothelin-1 in vasoactive concentration (0.1 μg/100 g) decreased
choleresis with maximum reduction by 15.5% (p b 0.05) in 40 min
following its administration and exhibited diverse effects on concen-
tration of different bile acids. Taurocholic acid was gradually reduced
in control and experimental animals, but its level was higher by 9.3%
(p b 0.05) in the sixth sample of experimental animals. Concentra-
tion of glycocholic acid was reduced in the control animals, but
increased following endothelin-1 administration by 12.3% (p b 0.05),
19.7% (p b 0.01), and 16.3% (p b 0.01) in the last three bile samples
correspondingly. Endothelin-1 caused an increase of free bile acids.
Concentration of cholic acid increased in the third and sixth samples
by 20.6% and 19.8% (p b 0.05) respectively. Phospholipids increased
in the ﬁfth bile sample in endothelin-1 action by 16.7% (p b 0.05).
Free cholesterol decreased slightly but ether-coupled cholesterol in-
creased in the last two samples by 43.8% (p b 0.05) and 45.7% (p b 0.05)
respectively. Triglycerides increased gradually and 50% (p b 0.05)
elevation was found in the fourth bile sample. So endothelin-1 inten-
siﬁes conjugation of the free bile acids and biosynthesis of ether-
coupled cholesterol, trihydroxycholane acids and phospholipids in liver
that assist in the improvement of bile colloidal system characteristics.
doi:10.1016/j.lfs.2013.12.058
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The endothelin system consists of three ligands (ET-1, ET-2 and
ET-3) and at least two receptors (ETA and ETB). In intestinal villi,
ﬁbroblast-like cells express endothelin receptors and response to
ET-1 and ET-3 peptides, changing their cellular shape. Several func-
tions have been attributed to these peptides in the “architecture”
maintenance of intestinal villi acting over sub-epithelial ﬁbroblasts.
Despite this, ET-2 has not been analyzed in depth. In this work we
show the intestine gene expression and immunolocalization of ET-1,
ET-2 and ETA and ETB receptors from the duodenum to the rectus
and in the villus–crypt axis in mice, allowing a complete analysis
of their functions. While ET-1 is expressed uniformly, ET-2 had a
particular distribution, being higher at the bottom of the villi of the
duodenum, ileum and jejunum and reverting this pattern in the
crypts of the colon and rectus, where the higher expression was at
the top. We postulated that ET-2 would act in a cooperative manner
with ET-1, giving the villus the strength enough towithstandmechanical
stress.
doi:10.1016/j.lfs.2013.12.059
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The effects of hormone replacement therapy with estrogen on
cardiovascular disease in post menopausal women are still con-
troversial. We previously reported that endothelin (ET)-1/ET recep-
tor system is involved in sex differences in the development of
neointimal formation after vascular injury. In the present study, we
hypothesized that dual ETA/ETB receptor antagonist (ERA) could
exhibit vasoprotective effects after menopause. To conﬁrm it, we
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examined the effects of ERA and/or angiotensin receptor blocker
(ARB) on neointimal formation after vascular injury in intact and
ovariectomized (OVX) female rats. The right carotid artery was ex-
posed to balloon injury, and harvested 2 weeks after the injury. In
intact female groups, treatmentwith ARB for twoweeks after the injury
signiﬁcantly decreased neointimal formation, whereas treatment with
ERA did not affect neointimal formation. On the other hand, in the
OVX groups, ET antagonist markedly decreased neointimal formation
after the injury although neointimal formation was not signiﬁcantly
improved by ARB. Combined treatment with 17β-estradiol and ARB
markedly suppressed neointimal formation after the injury in the
OVX groups, whereas there were no additive effects during combined
treatment with 17β-estradiol and ERA. These ERA or 17β-estradiol-
induced vasoprotective effects in the OVX groups were related to the
suppression of NADPH oxydase-dependent reactive oxygen species
production. Taken together, ERA has an estrogen-like vasoprotective
action on neointimal formation via inhibition of oxidative stress. ERA
may be an alternative therapy for the prevention of vascular disease in
postmenopausal women.
doi:10.1016/j.lfs.2013.12.060
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Obstructive sleep apnea (OSA) has been identiﬁed as a signiﬁcant
risk factor for stroke. However, little is known regarding the effects
of OSA on the cerebrovascular wall. We hypothesized that OSA
augments endothelin-1 (ET-1) induced constrictions of cerebral
arteries. Using rats chronically instrumented with an inﬂatable
endotracheal obstruction device we simulated a moderate severity
of sleep apnea, 30 apneas/h for 8 h/day (sleep phase) for 1 month.
Cerebral arteries were harvested for analysis of gene-expression,
immunohistochemistry, and vascular reactivity. Following 1 month
of OSA, blood pressure and plasma/cerebral vessel ET-1 levels were
similar in sham and OSA rats (n = 4–7, NS). Using the pressurized
cerebral artery preparation, we observed a 17.5-fold increase in
sensitivity to ET-1 (n = 5–6, p b 0.05). The increased sensitivity of
OSA cerebral arteries to ET-1 was abolished by the ET-B receptor
antagonist BQ-788 (n = 6, NS). However, increased ET-1 sensitivity
of OSA cerebral arteries persisted in the presence of the ET-A
receptor antagonist BQ-123 (n = 3–6, p b 0.05). Additionally, con-
strictions to the ET-B speciﬁc agonist IRL-1620 were signiﬁcantly
greater in OSA, versus sham, cerebral arteries (n = 6, p b 0.05). Gene
expression analysis revealed no difference in the mRNA levels of ET-
1, ET-a or ET-b receptors, or endothelin converting enzyme (ece1)
(n = 6, NS). However, immunohistochemical analysis demonstrated
elevated levels of ET-B receptor in the smooth muscle of OSA
cerebral arteries. These data demonstrate that OSA increases the
sensitivity of cerebral arteries to ET-1, which appears to be driven by
increased ET-B receptor signaling. These observations suggest an
important role of ET-1 signaling in the adverse cerebrovascular
outcomes associated with OSA.
doi:10.1016/j.lfs.2013.12.061
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We found that the ETB receptor agonist, IRL-1620, provides
signiﬁcant neuroprotection following permanent cerebral ischemia.
The serine/threonine kinase Akt plays a role in regulating cell
survival and death cascades, and may mediate the neuroprotective
effect of IRL-1620. The present study investigated the effect of IRL-
1620 on the phosphorylation state of Akt in a rat model of cerebral
ischemia. Male Sprague–Dawley rats underwent permanent middle
cerebral artery occlusion. Following surgery, rats received three
intravenous injections of vehicle or IRL-1620 (5 μg/kg) at 2, 4, and
6 h post-occlusion. Evaluation of behavioral parameters conﬁrmed
the induction of stroke. Animals were sacriﬁced 7 and 24 h following
occlusion and brains were processed to evaluate protein expression
of total Akt and Akt phosphorylated at Ser473. There were no sig-
niﬁcant changes in behavioral parameters between the vehicle and
IRL-1620 groups 7 h post-occlusion. However, at 24 h there was a
marked improvement in the behavioral parameters of IRL-1620
compared to vehicle treated rats. There were no changes in total Akt
expression levels in the brains of sham, vehicle, and IRL-1620 treated
rats; however, there was an increase in the phosphorylation of
Ser473 of Akt (p473-Akt) in the IRL-1620 treated rats compared to
sham (P&lt0.01) or vehicle treated (P&lt0.05) rats 7 h post-occlusion.
No difference in total Akt or p473-Akt levels was observed 24 h post-
occlusion in the brains of sham, vehicle, or IRL-1620 treated rats. It is
concluded that IRL-1620 causes a transient elevation in phosphoryla-
tion of Ser473 after 7 h of cerebral ischemia, suggesting that the Akt
pathway may be involved in mediating the neuroprotective effect of
IRL-1620.
doi:10.1016/j.lfs.2013.12.062
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Sepsis is a disease of the microcirculation, with endothelial
dysfunction playing a key role in its pathogenesis and subsequent
associated mortality. Pathophysiology of brain dysfunction due to
sepsis remains poorly understood. Cerebral microcirculatory alter-
ations may play a potential role; however, experimental data are
scarce. The present study sought to investigate whether key angio-
genic pathways are altered in the frontal cortex in a clinically
relevant animal model of endotoxemia/sepsis. Male mice at 8 weeks
of age were administered either saline or 20 mg/kg lipopolysaccha-
ride (LPS) at different time points (1, 3, 6, and 10 h). Mice that did
not receive LPS were considered to be controls. We conﬁrmed the
induction of endotoxemia by measuring circulatory TNF-alpha level
as well as cerebral mRNA levels of TNF-alpha, IL-1beta, and IL-6.
Vascular endothelial growth factor (VEGF), a major vascular multi-
factorial cytokine involved in all the three types of vascular growth
namely, angiogenesis, arteriogenesis and atherogenesis, mediates its
angiogenic action through its receptor VEGF-R2. In the frontal cortex
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